247
Views
12
CrossRef citations to date
0
Altmetric
IMAGING, DIAGNOSIS, PROGNOSIS

Evaluation of Soluble Mesothelin-related Peptide as a Diagnostic Marker of Malignant Pleural Mesothelioma Effusions: Its Contribution to Cytology

, , , , , , , , , , & show all
Pages 43-50 | Published online: 18 Dec 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kamal Asgarov, Jeremy Balland, Charline Tirole, Adeline Bouard, Virginie Mougey, Diana Ramos, António Barroso, Vincent Zangiacomi, Marine Jary, Stefano Kim, Maria Gonzalez-Pajuelo, Bernard Royer, Hans de Haard, Andy Clark, John Wijdenes & Christophe Borg. (2017) A new anti-mesothelin antibody targets selectively the membrane-associated form. mAbs 9:3, pages 567-577.
Read now

Articles from other publishers (11)

Zhenhua Lu, Wenlong Zhang, Ke Huang, Mucheng Zhu, Xiaoting Gu, Defang Wei, Mingxuan Shi, Yaqiong Chen & Huihui Wang. (2022) Systematic Review, Meta-Analysis and Bioinformatic Analysis of Biomarkers for Prognosis of Malignant Pleural Mesothelioma. Diagnostics 12:9, pages 2210.
Crossref
Eline Schillebeeckx, Jan P. van Meerbeeck & Kevin Lamote. (2021) Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis. European Respiratory Review 30:162, pages 210057.
Crossref
Christina N Gillezeau, Maaike van Gerwen, Julio Ramos, Bian Liu, Raja Flores & Emanuela Taioli. (2019) Biomarkers for malignant pleural mesothelioma: a meta-analysis. Carcinogenesis 40:11, pages 1320-1331.
Crossref
Caterina Ledda, Rosario Caltabiano, Francesca Vella, Serena Matera, Andrea Marconi, Carla Loreto & Venerando Rapisarda. (2019) Fibulin-3 as biomarker of malignant mesothelioma. Biomarkers in Medicine 13:10, pages 875-886.
Crossref
Ruiyue Gao, Feng Wang, Zhen Wang, Yanbing Wu, Lili Xu, Yue Qin, Huanzhong Shi & Zhaohui Tong. (2019) Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma. Medicine 98:14, pages e14979.
Crossref
Lourdes Cortes-Dericks & Ralph Alexander Schmid. (2017) CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives. Respiratory Research 18:1.
Crossref
Takehiro Otoshi, Yuki Kataoka, Shunkichi Ikegaki, Emiko Saito, Hirotaka Matsumoto, Sawako Kaku, Masatoshi Shimada & Masataka Hirabayashi. (2017) Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center. PLOS ONE 12:10, pages e0185850.
Crossref
Jenette Creaney & Bruce W.S. Robinson. (2017) Malignant Mesothelioma Biomarkers. Chest 152:1, pages 143-149.
Crossref
Melike Demir, Halide Kaya, Mahsuk Taylan, Aysun Ekinci, Sureyya Yılmaz, Fatma Teke, Cengizhan Sezgi, Abdullah Cetin Tanrikulu, Fatih Meteroglu & Abdurrahman Senyigit. (2016) Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure. Lung 194:3, pages 409-417.
Crossref
Pier Aldo Canessa, Paola Ferro, Carmen Manta, Massimiliano Sivori, Maria Cristiana Franceschini, Franco Fedeli & Silvio Roncella. (2013) Clinical value of mesothelin in pleural effusions versus histology by medical thoracoscopy: brief report. Medical Oncology 30:3.
Crossref
Rosa Filiberti, Stefano Parodi, Roberta Libener, Giovanni Paolo Ivaldi, Pier Aldo Canessa, Donatella Ugolini, Barbara Bobbio & Paola Marroni. (2013) Diagnostic value of mesothelin in pleural fluids: comparison with CYFRA 21-1 and CEA. Medical Oncology 30:2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.